Global Biosimilar Drug Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Biosimilar Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.
East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.
In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.
LP Information, Inc. (LPI) ' newest research report, the “Biosimilar Drug Industry Forecast” looks at past sales and reviews total world Biosimilar Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Biosimilar Drug sales for 2025 through 2031. With Biosimilar Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biosimilar Drug industry.
This Insight Report provides a comprehensive analysis of the global Biosimilar Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biosimilar Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biosimilar Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biosimilar Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biosimilar Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Biosimilar Drug market?
What factors are driving Biosimilar Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biosimilar Drug market opportunities vary by end market size?
How does Biosimilar Drug break out by Type, by Application?
The global Biosimilar Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.
East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.
In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.
LP Information, Inc. (LPI) ' newest research report, the “Biosimilar Drug Industry Forecast” looks at past sales and reviews total world Biosimilar Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Biosimilar Drug sales for 2025 through 2031. With Biosimilar Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biosimilar Drug industry.
This Insight Report provides a comprehensive analysis of the global Biosimilar Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biosimilar Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biosimilar Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biosimilar Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biosimilar Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection
- Tablets
- Other Types
- Ankylosing Spondylitis
- Tumor
- Rheumatoid Arthrtis
- Cardiovascular
- Other Application
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CP Guojian Pharma
- Biotech Pharma
- Celgen Pharma
- Henlius
- Amgen
- Eli Lilly
- Sandoz
- Changchun High Tech
- Innovent
What is the 10-year outlook for the global Biosimilar Drug market?
What factors are driving Biosimilar Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biosimilar Drug market opportunities vary by end market size?
How does Biosimilar Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilar Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Biosimilar Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Biosimilar Drug by Country/Region, 2020, 2024 & 2031
2.2 Biosimilar Drug Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Other Types
2.3 Biosimilar Drug Sales by Type
2.3.1 Global Biosimilar Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Biosimilar Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Biosimilar Drug Sale Price by Type (2020-2025)
2.4 Biosimilar Drug Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Tumor
2.4.3 Rheumatoid Arthrtis
2.4.4 Cardiovascular
2.4.5 Other Application
2.5 Biosimilar Drug Sales by Application
2.5.1 Global Biosimilar Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Biosimilar Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Biosimilar Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Biosimilar Drug Breakdown Data by Company
3.1.1 Global Biosimilar Drug Annual Sales by Company (2020-2025)
3.1.2 Global Biosimilar Drug Sales Market Share by Company (2020-2025)
3.2 Global Biosimilar Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Biosimilar Drug Revenue by Company (2020-2025)
3.2.2 Global Biosimilar Drug Revenue Market Share by Company (2020-2025)
3.3 Global Biosimilar Drug Sale Price by Company
3.4 Key Manufacturers Biosimilar Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilar Drug Product Location Distribution
3.4.2 Players Biosimilar Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIOSIMILAR DRUG BY GEOGRAPHIC REGION
4.1 World Historic Biosimilar Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Biosimilar Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Biosimilar Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Biosimilar Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Biosimilar Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Biosimilar Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biosimilar Drug Sales Growth
4.4 APAC Biosimilar Drug Sales Growth
4.5 Europe Biosimilar Drug Sales Growth
4.6 Middle East & Africa Biosimilar Drug Sales Growth
5 AMERICAS
5.1 Americas Biosimilar Drug Sales by Country
5.1.1 Americas Biosimilar Drug Sales by Country (2020-2025)
5.1.2 Americas Biosimilar Drug Revenue by Country (2020-2025)
5.2 Americas Biosimilar Drug Sales by Type (2020-2025)
5.3 Americas Biosimilar Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Drug Sales by Region
6.1.1 APAC Biosimilar Drug Sales by Region (2020-2025)
6.1.2 APAC Biosimilar Drug Revenue by Region (2020-2025)
6.2 APAC Biosimilar Drug Sales by Type (2020-2025)
6.3 APAC Biosimilar Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biosimilar Drug by Country
7.1.1 Europe Biosimilar Drug Sales by Country (2020-2025)
7.1.2 Europe Biosimilar Drug Revenue by Country (2020-2025)
7.2 Europe Biosimilar Drug Sales by Type (2020-2025)
7.3 Europe Biosimilar Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilar Drug by Country
8.1.1 Middle East & Africa Biosimilar Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Biosimilar Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Biosimilar Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Biosimilar Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biosimilar Drug
10.3 Manufacturing Process Analysis of Biosimilar Drug
10.4 Industry Chain Structure of Biosimilar Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biosimilar Drug Distributors
11.3 Biosimilar Drug Customer
12 WORLD FORECAST REVIEW FOR BIOSIMILAR DRUG BY GEOGRAPHIC REGION
12.1 Global Biosimilar Drug Market Size Forecast by Region
12.1.1 Global Biosimilar Drug Forecast by Region (2026-2031)
12.1.2 Global Biosimilar Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Biosimilar Drug Forecast by Type (2026-2031)
12.7 Global Biosimilar Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CP Guojian Pharma
13.1.1 CP Guojian Pharma Company Information
13.1.2 CP Guojian Pharma Biosimilar Drug Product Portfolios and Specifications
13.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CP Guojian Pharma Main Business Overview
13.1.5 CP Guojian Pharma Latest Developments
13.2 Biotech Pharma
13.2.1 Biotech Pharma Company Information
13.2.2 Biotech Pharma Biosimilar Drug Product Portfolios and Specifications
13.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Biotech Pharma Main Business Overview
13.2.5 Biotech Pharma Latest Developments
13.3 Celgen Pharma
13.3.1 Celgen Pharma Company Information
13.3.2 Celgen Pharma Biosimilar Drug Product Portfolios and Specifications
13.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Celgen Pharma Main Business Overview
13.3.5 Celgen Pharma Latest Developments
13.4 Henlius
13.4.1 Henlius Company Information
13.4.2 Henlius Biosimilar Drug Product Portfolios and Specifications
13.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Henlius Main Business Overview
13.4.5 Henlius Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen Biosimilar Drug Product Portfolios and Specifications
13.5.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Biosimilar Drug Product Portfolios and Specifications
13.6.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Biosimilar Drug Product Portfolios and Specifications
13.7.3 Sandoz Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 Changchun High Tech
13.8.1 Changchun High Tech Company Information
13.8.2 Changchun High Tech Biosimilar Drug Product Portfolios and Specifications
13.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Changchun High Tech Main Business Overview
13.8.5 Changchun High Tech Latest Developments
13.9 Innovent
13.9.1 Innovent Company Information
13.9.2 Innovent Biosimilar Drug Product Portfolios and Specifications
13.9.3 Innovent Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Innovent Main Business Overview
13.9.5 Innovent Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Biosimilar Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Biosimilar Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players ofTablets
Table 5. Major Players of OtherTypes
Table 6. Global Biosimilar Drug Sales byType (2020-2025) & (K Dose)
Table 7. Global Biosimilar Drug Sales Market Share byType (2020-2025)
Table 8. Global Biosimilar Drug Revenue byType (2020-2025) & ($ million)
Table 9. Global Biosimilar Drug Revenue Market Share byType (2020-2025)
Table 10. Global Biosimilar Drug Sale Price byType (2020-2025) & (USD/Dose)
Table 11. Global Biosimilar Drug Sale by Application (2020-2025) & (K Dose)
Table 12. Global Biosimilar Drug Sale Market Share by Application (2020-2025)
Table 13. Global Biosimilar Drug Revenue by Application (2020-2025) & ($ million)
Table 14. Global Biosimilar Drug Revenue Market Share by Application (2020-2025)
Table 15. Global Biosimilar Drug Sale Price by Application (2020-2025) & (USD/Dose)
Table 16. Global Biosimilar Drug Sales by Company (2020-2025) & (K Dose)
Table 17. Global Biosimilar Drug Sales Market Share by Company (2020-2025)
Table 18. Global Biosimilar Drug Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Biosimilar Drug Revenue Market Share by Company (2020-2025)
Table 20. Global Biosimilar Drug Sale Price by Company (2020-2025) & (USD/Dose)
Table 21. Key Manufacturers Biosimilar Drug Producing Area Distribution and Sales Area
Table 22. Players Biosimilar Drug Products Offered
Table 23. Biosimilar Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Biosimilar Drug Sales by Geographic Region (2020-2025) & (K Dose)
Table 27. Global Biosimilar Drug Sales Market Share Geographic Region (2020-2025)
Table 28. Global Biosimilar Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Biosimilar Drug Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Biosimilar Drug Sales by Country/Region (2020-2025) & (K Dose)
Table 31. Global Biosimilar Drug Sales Market Share by Country/Region (2020-2025)
Table 32. Global Biosimilar Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Biosimilar Drug Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 35. Americas Biosimilar Drug Sales Market Share by Country (2020-2025)
Table 36. Americas Biosimilar Drug Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Biosimilar Drug Sales byType (2020-2025) & (K Dose)
Table 38. Americas Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 39. APAC Biosimilar Drug Sales by Region (2020-2025) & (K Dose)
Table 40. APAC Biosimilar Drug Sales Market Share by Region (2020-2025)
Table 41. APAC Biosimilar Drug Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Biosimilar Drug Sales byType (2020-2025) & (K Dose)
Table 43. APAC Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 44. Europe Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 45. Europe Biosimilar Drug Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Biosimilar Drug Sales byType (2020-2025) & (K Dose)
Table 47. Europe Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 48. Middle East & Africa Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 49. Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Biosimilar Drug Sales byType (2020-2025) & (K Dose)
Table 51. Middle East & Africa Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 52. Key Market Drivers & Growth Opportunities of Biosimilar Drug
Table 53. Key Market Challenges & Risks of Biosimilar Drug
Table 54. Key IndustryTrends of Biosimilar Drug
Table 55. Biosimilar Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Biosimilar Drug Distributors List
Table 58. Biosimilar Drug Customer List
Table 59. Global Biosimilar Drug SalesForecast by Region (2026-2031) & (K Dose)
Table 60. Global Biosimilar Drug RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Biosimilar Drug SalesForecast by Country (2026-2031) & (K Dose)
Table 62. Americas Biosimilar Drug Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Biosimilar Drug SalesForecast by Region (2026-2031) & (K Dose)
Table 64. APAC Biosimilar Drug Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Biosimilar Drug SalesForecast by Country (2026-2031) & (K Dose)
Table 66. Europe Biosimilar Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Biosimilar Drug SalesForecast by Country (2026-2031) & (K Dose)
Table 68. Middle East & Africa Biosimilar Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Biosimilar Drug SalesForecast byType (2026-2031) & (K Dose)
Table 70. Global Biosimilar Drug RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Biosimilar Drug SalesForecast by Application (2026-2031) & (K Dose)
Table 72. Global Biosimilar Drug RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. CP Guojian Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. CP Guojian Pharma Biosimilar Drug Product Portfolios and Specifications
Table 75. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 76. CP Guojian Pharma Main Business
Table 77. CP Guojian Pharma Latest Developments
Table 78. Biotech Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Biotech Pharma Biosimilar Drug Product Portfolios and Specifications
Table 80. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. Biotech Pharma Main Business
Table 82. Biotech Pharma Latest Developments
Table 83. Celgen Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Celgen Pharma Biosimilar Drug Product Portfolios and Specifications
Table 85. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. Celgen Pharma Main Business
Table 87. Celgen Pharma Latest Developments
Table 88. Henlius Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Henlius Biosimilar Drug Product Portfolios and Specifications
Table 90. Henlius Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. Henlius Main Business
Table 92. Henlius Latest Developments
Table 93. Amgen Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen Biosimilar Drug Product Portfolios and Specifications
Table 95. Amgen Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Amgen Main Business
Table 97. Amgen Latest Developments
Table 98. Eli Lilly Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Eli Lilly Biosimilar Drug Product Portfolios and Specifications
Table 100. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 101. Eli Lilly Main Business
Table 102. Eli Lilly Latest Developments
Table 103. Sandoz Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Sandoz Biosimilar Drug Product Portfolios and Specifications
Table 105. Sandoz Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 106. Sandoz Main Business
Table 107. Sandoz Latest Developments
Table 108. Changchun HighTech Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Changchun HighTech Biosimilar Drug Product Portfolios and Specifications
Table 110. Changchun HighTech Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 111. Changchun HighTech Main Business
Table 112. Changchun HighTech Latest Developments
Table 113. Innovent Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Innovent Biosimilar Drug Product Portfolios and Specifications
Table 115. Innovent Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 116. Innovent Main Business
Table 117. Innovent Latest Developments
LIST OFFIGURES
Figure 1. Picture of Biosimilar Drug
Figure 2. Biosimilar Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilar Drug Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Biosimilar Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Biosimilar Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Biosimilar Drug Sales Market Share by Country/Region (2024)
Figure 10. Biosimilar Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture ofTablets
Figure 13. Product Picture of OtherTypes
Figure 14. Global Biosimilar Drug Sales Market Share byType in 2025
Figure 15. Global Biosimilar Drug Revenue Market Share byType (2020-2025)
Figure 16. Biosimilar Drug Consumed in Ankylosing Spondylitis
Figure 17. Global Biosimilar Drug Market: Ankylosing Spondylitis (2020-2025) & (K Dose)
Figure 18. Biosimilar Drug Consumed inTumor
Figure 19. Global Biosimilar Drug Market:Tumor (2020-2025) & (K Dose)
Figure 20. Biosimilar Drug Consumed in Rheumatoid Arthrtis
Figure 21. Global Biosimilar Drug Market: Rheumatoid Arthrtis (2020-2025) & (K Dose)
Figure 22. Biosimilar Drug Consumed in Cardiovascular
Figure 23. Global Biosimilar Drug Market: Cardiovascular (2020-2025) & (K Dose)
Figure 24. Biosimilar Drug Consumed in Other Application
Figure 25. Global Biosimilar Drug Market: Other Application (2020-2025) & (K Dose)
Figure 26. Global Biosimilar Drug Sale Market Share by Application (2024)
Figure 27. Global Biosimilar Drug Revenue Market Share by Application in 2025
Figure 28. Biosimilar Drug Sales by Company in 2025 (K Dose)
Figure 29. Global Biosimilar Drug Sales Market Share by Company in 2025
Figure 30. Biosimilar Drug Revenue by Company in 2025 ($ millions)
Figure 31. Global Biosimilar Drug Revenue Market Share by Company in 2025
Figure 32. Global Biosimilar Drug Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Biosimilar Drug Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Biosimilar Drug Sales 2020-2025 (K Dose)
Figure 35. Americas Biosimilar Drug Revenue 2020-2025 ($ millions)
Figure 36. APAC Biosimilar Drug Sales 2020-2025 (K Dose)
Figure 37. APAC Biosimilar Drug Revenue 2020-2025 ($ millions)
Figure 38. Europe Biosimilar Drug Sales 2020-2025 (K Dose)
Figure 39. Europe Biosimilar Drug Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Biosimilar Drug Sales 2020-2025 (K Dose)
Figure 41. Middle East & Africa Biosimilar Drug Revenue 2020-2025 ($ millions)
Figure 42. Americas Biosimilar Drug Sales Market Share by Country in 2025
Figure 43. Americas Biosimilar Drug Revenue Market Share by Country (2020-2025)
Figure 44. Americas Biosimilar Drug Sales Market Share byType (2020-2025)
Figure 45. Americas Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 46. United States Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Biosimilar Drug Sales Market Share by Region in 2025
Figure 51. APAC Biosimilar Drug Revenue Market Share by Region (2020-2025)
Figure 52. APAC Biosimilar Drug Sales Market Share byType (2020-2025)
Figure 53. APAC Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 54. China Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. India Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Biosimilar Drug Sales Market Share by Country in 2025
Figure 62. Europe Biosimilar Drug Revenue Market Share by Country (2020-2025)
Figure 63. Europe Biosimilar Drug Sales Market Share byType (2020-2025)
Figure 64. Europe Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 65. Germany Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 66.France Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Biosimilar Drug Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Biosimilar Drug Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 73. Egypt Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Biosimilar Drug in 2025
Figure 79. Manufacturing Process Analysis of Biosimilar Drug
Figure 80. Industry Chain Structure of Biosimilar Drug
Figure 81. Channels of Distribution
Figure 82. Global Biosimilar Drug Sales MarketForecast by Region (2026-2031)
Figure 83. Global Biosimilar Drug Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Biosimilar Drug Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Biosimilar Drug Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Biosimilar Drug Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Biosimilar Drug Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilar Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Biosimilar Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Biosimilar Drug by Country/Region, 2020, 2024 & 2031
2.2 Biosimilar Drug Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Other Types
2.3 Biosimilar Drug Sales by Type
2.3.1 Global Biosimilar Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Biosimilar Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Biosimilar Drug Sale Price by Type (2020-2025)
2.4 Biosimilar Drug Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Tumor
2.4.3 Rheumatoid Arthrtis
2.4.4 Cardiovascular
2.4.5 Other Application
2.5 Biosimilar Drug Sales by Application
2.5.1 Global Biosimilar Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Biosimilar Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Biosimilar Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Biosimilar Drug Breakdown Data by Company
3.1.1 Global Biosimilar Drug Annual Sales by Company (2020-2025)
3.1.2 Global Biosimilar Drug Sales Market Share by Company (2020-2025)
3.2 Global Biosimilar Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Biosimilar Drug Revenue by Company (2020-2025)
3.2.2 Global Biosimilar Drug Revenue Market Share by Company (2020-2025)
3.3 Global Biosimilar Drug Sale Price by Company
3.4 Key Manufacturers Biosimilar Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilar Drug Product Location Distribution
3.4.2 Players Biosimilar Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIOSIMILAR DRUG BY GEOGRAPHIC REGION
4.1 World Historic Biosimilar Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Biosimilar Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Biosimilar Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Biosimilar Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Biosimilar Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Biosimilar Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biosimilar Drug Sales Growth
4.4 APAC Biosimilar Drug Sales Growth
4.5 Europe Biosimilar Drug Sales Growth
4.6 Middle East & Africa Biosimilar Drug Sales Growth
5 AMERICAS
5.1 Americas Biosimilar Drug Sales by Country
5.1.1 Americas Biosimilar Drug Sales by Country (2020-2025)
5.1.2 Americas Biosimilar Drug Revenue by Country (2020-2025)
5.2 Americas Biosimilar Drug Sales by Type (2020-2025)
5.3 Americas Biosimilar Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Drug Sales by Region
6.1.1 APAC Biosimilar Drug Sales by Region (2020-2025)
6.1.2 APAC Biosimilar Drug Revenue by Region (2020-2025)
6.2 APAC Biosimilar Drug Sales by Type (2020-2025)
6.3 APAC Biosimilar Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biosimilar Drug by Country
7.1.1 Europe Biosimilar Drug Sales by Country (2020-2025)
7.1.2 Europe Biosimilar Drug Revenue by Country (2020-2025)
7.2 Europe Biosimilar Drug Sales by Type (2020-2025)
7.3 Europe Biosimilar Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilar Drug by Country
8.1.1 Middle East & Africa Biosimilar Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Biosimilar Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Biosimilar Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Biosimilar Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biosimilar Drug
10.3 Manufacturing Process Analysis of Biosimilar Drug
10.4 Industry Chain Structure of Biosimilar Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biosimilar Drug Distributors
11.3 Biosimilar Drug Customer
12 WORLD FORECAST REVIEW FOR BIOSIMILAR DRUG BY GEOGRAPHIC REGION
12.1 Global Biosimilar Drug Market Size Forecast by Region
12.1.1 Global Biosimilar Drug Forecast by Region (2026-2031)
12.1.2 Global Biosimilar Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Biosimilar Drug Forecast by Type (2026-2031)
12.7 Global Biosimilar Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CP Guojian Pharma
13.1.1 CP Guojian Pharma Company Information
13.1.2 CP Guojian Pharma Biosimilar Drug Product Portfolios and Specifications
13.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CP Guojian Pharma Main Business Overview
13.1.5 CP Guojian Pharma Latest Developments
13.2 Biotech Pharma
13.2.1 Biotech Pharma Company Information
13.2.2 Biotech Pharma Biosimilar Drug Product Portfolios and Specifications
13.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Biotech Pharma Main Business Overview
13.2.5 Biotech Pharma Latest Developments
13.3 Celgen Pharma
13.3.1 Celgen Pharma Company Information
13.3.2 Celgen Pharma Biosimilar Drug Product Portfolios and Specifications
13.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Celgen Pharma Main Business Overview
13.3.5 Celgen Pharma Latest Developments
13.4 Henlius
13.4.1 Henlius Company Information
13.4.2 Henlius Biosimilar Drug Product Portfolios and Specifications
13.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Henlius Main Business Overview
13.4.5 Henlius Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen Biosimilar Drug Product Portfolios and Specifications
13.5.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Biosimilar Drug Product Portfolios and Specifications
13.6.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Biosimilar Drug Product Portfolios and Specifications
13.7.3 Sandoz Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 Changchun High Tech
13.8.1 Changchun High Tech Company Information
13.8.2 Changchun High Tech Biosimilar Drug Product Portfolios and Specifications
13.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Changchun High Tech Main Business Overview
13.8.5 Changchun High Tech Latest Developments
13.9 Innovent
13.9.1 Innovent Company Information
13.9.2 Innovent Biosimilar Drug Product Portfolios and Specifications
13.9.3 Innovent Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Innovent Main Business Overview
13.9.5 Innovent Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Biosimilar Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Biosimilar Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players ofTablets
Table 5. Major Players of OtherTypes
Table 6. Global Biosimilar Drug Sales byType (2020-2025) & (K Dose)
Table 7. Global Biosimilar Drug Sales Market Share byType (2020-2025)
Table 8. Global Biosimilar Drug Revenue byType (2020-2025) & ($ million)
Table 9. Global Biosimilar Drug Revenue Market Share byType (2020-2025)
Table 10. Global Biosimilar Drug Sale Price byType (2020-2025) & (USD/Dose)
Table 11. Global Biosimilar Drug Sale by Application (2020-2025) & (K Dose)
Table 12. Global Biosimilar Drug Sale Market Share by Application (2020-2025)
Table 13. Global Biosimilar Drug Revenue by Application (2020-2025) & ($ million)
Table 14. Global Biosimilar Drug Revenue Market Share by Application (2020-2025)
Table 15. Global Biosimilar Drug Sale Price by Application (2020-2025) & (USD/Dose)
Table 16. Global Biosimilar Drug Sales by Company (2020-2025) & (K Dose)
Table 17. Global Biosimilar Drug Sales Market Share by Company (2020-2025)
Table 18. Global Biosimilar Drug Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Biosimilar Drug Revenue Market Share by Company (2020-2025)
Table 20. Global Biosimilar Drug Sale Price by Company (2020-2025) & (USD/Dose)
Table 21. Key Manufacturers Biosimilar Drug Producing Area Distribution and Sales Area
Table 22. Players Biosimilar Drug Products Offered
Table 23. Biosimilar Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Biosimilar Drug Sales by Geographic Region (2020-2025) & (K Dose)
Table 27. Global Biosimilar Drug Sales Market Share Geographic Region (2020-2025)
Table 28. Global Biosimilar Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Biosimilar Drug Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Biosimilar Drug Sales by Country/Region (2020-2025) & (K Dose)
Table 31. Global Biosimilar Drug Sales Market Share by Country/Region (2020-2025)
Table 32. Global Biosimilar Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Biosimilar Drug Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 35. Americas Biosimilar Drug Sales Market Share by Country (2020-2025)
Table 36. Americas Biosimilar Drug Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Biosimilar Drug Sales byType (2020-2025) & (K Dose)
Table 38. Americas Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 39. APAC Biosimilar Drug Sales by Region (2020-2025) & (K Dose)
Table 40. APAC Biosimilar Drug Sales Market Share by Region (2020-2025)
Table 41. APAC Biosimilar Drug Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Biosimilar Drug Sales byType (2020-2025) & (K Dose)
Table 43. APAC Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 44. Europe Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 45. Europe Biosimilar Drug Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Biosimilar Drug Sales byType (2020-2025) & (K Dose)
Table 47. Europe Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 48. Middle East & Africa Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 49. Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Biosimilar Drug Sales byType (2020-2025) & (K Dose)
Table 51. Middle East & Africa Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 52. Key Market Drivers & Growth Opportunities of Biosimilar Drug
Table 53. Key Market Challenges & Risks of Biosimilar Drug
Table 54. Key IndustryTrends of Biosimilar Drug
Table 55. Biosimilar Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Biosimilar Drug Distributors List
Table 58. Biosimilar Drug Customer List
Table 59. Global Biosimilar Drug SalesForecast by Region (2026-2031) & (K Dose)
Table 60. Global Biosimilar Drug RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Biosimilar Drug SalesForecast by Country (2026-2031) & (K Dose)
Table 62. Americas Biosimilar Drug Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Biosimilar Drug SalesForecast by Region (2026-2031) & (K Dose)
Table 64. APAC Biosimilar Drug Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Biosimilar Drug SalesForecast by Country (2026-2031) & (K Dose)
Table 66. Europe Biosimilar Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Biosimilar Drug SalesForecast by Country (2026-2031) & (K Dose)
Table 68. Middle East & Africa Biosimilar Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Biosimilar Drug SalesForecast byType (2026-2031) & (K Dose)
Table 70. Global Biosimilar Drug RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Biosimilar Drug SalesForecast by Application (2026-2031) & (K Dose)
Table 72. Global Biosimilar Drug RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. CP Guojian Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. CP Guojian Pharma Biosimilar Drug Product Portfolios and Specifications
Table 75. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 76. CP Guojian Pharma Main Business
Table 77. CP Guojian Pharma Latest Developments
Table 78. Biotech Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Biotech Pharma Biosimilar Drug Product Portfolios and Specifications
Table 80. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. Biotech Pharma Main Business
Table 82. Biotech Pharma Latest Developments
Table 83. Celgen Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Celgen Pharma Biosimilar Drug Product Portfolios and Specifications
Table 85. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. Celgen Pharma Main Business
Table 87. Celgen Pharma Latest Developments
Table 88. Henlius Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Henlius Biosimilar Drug Product Portfolios and Specifications
Table 90. Henlius Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. Henlius Main Business
Table 92. Henlius Latest Developments
Table 93. Amgen Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen Biosimilar Drug Product Portfolios and Specifications
Table 95. Amgen Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Amgen Main Business
Table 97. Amgen Latest Developments
Table 98. Eli Lilly Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Eli Lilly Biosimilar Drug Product Portfolios and Specifications
Table 100. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 101. Eli Lilly Main Business
Table 102. Eli Lilly Latest Developments
Table 103. Sandoz Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Sandoz Biosimilar Drug Product Portfolios and Specifications
Table 105. Sandoz Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 106. Sandoz Main Business
Table 107. Sandoz Latest Developments
Table 108. Changchun HighTech Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Changchun HighTech Biosimilar Drug Product Portfolios and Specifications
Table 110. Changchun HighTech Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 111. Changchun HighTech Main Business
Table 112. Changchun HighTech Latest Developments
Table 113. Innovent Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Innovent Biosimilar Drug Product Portfolios and Specifications
Table 115. Innovent Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 116. Innovent Main Business
Table 117. Innovent Latest Developments
LIST OFFIGURES
Figure 1. Picture of Biosimilar Drug
Figure 2. Biosimilar Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilar Drug Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Biosimilar Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Biosimilar Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Biosimilar Drug Sales Market Share by Country/Region (2024)
Figure 10. Biosimilar Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture ofTablets
Figure 13. Product Picture of OtherTypes
Figure 14. Global Biosimilar Drug Sales Market Share byType in 2025
Figure 15. Global Biosimilar Drug Revenue Market Share byType (2020-2025)
Figure 16. Biosimilar Drug Consumed in Ankylosing Spondylitis
Figure 17. Global Biosimilar Drug Market: Ankylosing Spondylitis (2020-2025) & (K Dose)
Figure 18. Biosimilar Drug Consumed inTumor
Figure 19. Global Biosimilar Drug Market:Tumor (2020-2025) & (K Dose)
Figure 20. Biosimilar Drug Consumed in Rheumatoid Arthrtis
Figure 21. Global Biosimilar Drug Market: Rheumatoid Arthrtis (2020-2025) & (K Dose)
Figure 22. Biosimilar Drug Consumed in Cardiovascular
Figure 23. Global Biosimilar Drug Market: Cardiovascular (2020-2025) & (K Dose)
Figure 24. Biosimilar Drug Consumed in Other Application
Figure 25. Global Biosimilar Drug Market: Other Application (2020-2025) & (K Dose)
Figure 26. Global Biosimilar Drug Sale Market Share by Application (2024)
Figure 27. Global Biosimilar Drug Revenue Market Share by Application in 2025
Figure 28. Biosimilar Drug Sales by Company in 2025 (K Dose)
Figure 29. Global Biosimilar Drug Sales Market Share by Company in 2025
Figure 30. Biosimilar Drug Revenue by Company in 2025 ($ millions)
Figure 31. Global Biosimilar Drug Revenue Market Share by Company in 2025
Figure 32. Global Biosimilar Drug Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Biosimilar Drug Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Biosimilar Drug Sales 2020-2025 (K Dose)
Figure 35. Americas Biosimilar Drug Revenue 2020-2025 ($ millions)
Figure 36. APAC Biosimilar Drug Sales 2020-2025 (K Dose)
Figure 37. APAC Biosimilar Drug Revenue 2020-2025 ($ millions)
Figure 38. Europe Biosimilar Drug Sales 2020-2025 (K Dose)
Figure 39. Europe Biosimilar Drug Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Biosimilar Drug Sales 2020-2025 (K Dose)
Figure 41. Middle East & Africa Biosimilar Drug Revenue 2020-2025 ($ millions)
Figure 42. Americas Biosimilar Drug Sales Market Share by Country in 2025
Figure 43. Americas Biosimilar Drug Revenue Market Share by Country (2020-2025)
Figure 44. Americas Biosimilar Drug Sales Market Share byType (2020-2025)
Figure 45. Americas Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 46. United States Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Biosimilar Drug Sales Market Share by Region in 2025
Figure 51. APAC Biosimilar Drug Revenue Market Share by Region (2020-2025)
Figure 52. APAC Biosimilar Drug Sales Market Share byType (2020-2025)
Figure 53. APAC Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 54. China Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. India Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Biosimilar Drug Sales Market Share by Country in 2025
Figure 62. Europe Biosimilar Drug Revenue Market Share by Country (2020-2025)
Figure 63. Europe Biosimilar Drug Sales Market Share byType (2020-2025)
Figure 64. Europe Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 65. Germany Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 66.France Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Biosimilar Drug Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Biosimilar Drug Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 73. Egypt Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Biosimilar Drug Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Biosimilar Drug in 2025
Figure 79. Manufacturing Process Analysis of Biosimilar Drug
Figure 80. Industry Chain Structure of Biosimilar Drug
Figure 81. Channels of Distribution
Figure 82. Global Biosimilar Drug Sales MarketForecast by Region (2026-2031)
Figure 83. Global Biosimilar Drug Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Biosimilar Drug Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Biosimilar Drug Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Biosimilar Drug Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Biosimilar Drug Revenue Market ShareForecast by Application (2026-2031)
